Childhood immunizations: Position on the enhanced inactivated poliovirus vaccine and live attenuated oral poliovirus vaccine dilemma

Journal of the National Medical Association

Volumn 89, Issue 12, 1997, Pages 785-789

  Willis, Earnestine ^a   Sherrod, Jessie L ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

Enhanced inactivated poliovirus vaccine (eIPV); Live attenuated oral poliovirus vaccine (OPV); Poliomyelitis; Vaccines

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

AGE; ARTICLE; CHILD; COMPARATIVE STUDY; HEALTH CARE PLANNING; HUMAN; IMMUNIZATION; INFANT; POLIOMYELITIS; PRESCHOOL CHILD; VACCINATION;

AGE FACTORS; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MEDICALLY UNDERSERVED AREA; POLIOMYELITIS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; VACCINATION;

EID: 0031307729     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sutter RW, Onorato IM. Current poliomyelitis immunization policy in the United States. Pediatr Ann. 1990;19:702-706.
2. American Academy of Pediatrics. Report of the Committee on Infectious Diseases. In: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 1997:424-433.
3. Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. MMWR. 1997;46(RR-3):1-25.
4. Evans G. Vaccine liability and safety: a progress report. Pediatr Infect Dis J. 1996;15:477-478.
5. Kew, O. An assessment of the potential risks associated with the use of a combined schedule of attenuated and inactivated polio vaccines in the expanded program on immunization. Unpublished report submitted to the World Health Organization, 1992.
6. Strebel, PM, Sutter RW, Cochi SL, Biellik RJ, Brink EW, Kew OM, et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis. 1992;14(2):568-579.
7. Poliovirus immunization strategy: past, present and future. Immunization Focus, Quarterly on Immunization Practice. 1995;1:3-10.
8. Marwick C. Will US polio immunization rely on IPV or OPV? JAMA. 1995;274:12-23.
9. Centers for Disease Control and Prevention. Statement, Satcher D. Change offers children the best of both polio vaccines. CDC Media Relations. Sept 18, 1996.
10. Clinical update. Polio immunization policy in the US: a new direction or status quo? Vaccine Bulletin. May 1994:2-12.
11. Centers for Disease Control and Prevention. Immunization Action News. Dept of Health & Human Services; 1995:2(1):1-3.
12. Dagan R, Fraser D, Handsher R. Acquisition of immunity in mothers of infants administered trivalent oral poliovirus vaccine. Eur J Clin Microbiol Infect Dis. 1994;13:1029-1032.
13. Marwick C. Not everyone wants IPV; opposition gears up. JAMA. 1995;274:1574-1575.
14. Chen RT, Hausinger S, Dajani AS, Hanfling M, Baughman AL, Pallansch MA, et al. Seroprevalence of antibody against poliovirus in inner-city preschool children. JAMA. 1996;275:1638-1645.